# A human cerebral organoid model of West Nile virus encephalitis shows innate immunocompetency

**Authors:** Johanna Friederike Steffen, Lina Widerspick, Stephanie Jansen, Dennis Tappe

PMC · DOI: 10.1038/s41467-026-70281-x · 2026-03-07

## TL;DR

Researchers created a human brain model to study West Nile virus infection, finding it causes inflammation and affects neurons and astrocytes.

## Contribution

A novel human cerebral organoid model for studying West Nile virus encephalitis is developed.

## Key findings

- WNV infection in cerebral organoids shows heterogeneous viral replication kinetics with early and late peaks.
- Viral foci are found in neuron- and astrocyte-rich areas without microglia involvement.
- Infection leads to increased release of pro-inflammatory cytokines and biomarkers.

## Abstract

West Nile virus (WNV), an arbovirus of emerging global interest, can cause neuroinvasive disease in humans. Currently, no protective vaccine or specific treatment is available for human WNV encephalitis. The virus induces neuronal cell death, while astrocytes and microglia cells are suspected to contribute to WNV pathology. Hence, understanding their role is crucial for future treatment approaches. In this study, we establish a WNV encephalitis model using human cerebral organoids, generated with male iPSCs. Infection results in heterogeneous kinetics with an early strong replication potentially leading to viral clearance, while a late peak was associated with more long-term infection. Viral foci are seen in cortical-like areas, rich in neurons and astrocytes, however void of microglia. Pro-inflammatory cytokines (IL-6, TNF-α, IL-18), chemokines (CXCL10, CCL17, CX3CL1, CCL2) and biomarkers (IL-1RA, sTREM-1, sRAGE, BDNF) are increasingly released. Conclusively, human cerebral organoids make suitable WNV encephalitis models with valuable properties to study acute and long-term infection.

West Nile virus (WNV) can cause neuroinvasive disease. Here the authors develop a human cerebral organoid model for WNV infection and find heterogeneous viral kinetics with viral foci in neuron- and astrocyte-rich areas devoid of microglia, as well as increased release of cytokines and other biomarkers.

## Linked entities

- **Proteins:** IL6 (interleukin 6), TNF (tumor necrosis factor), IL18 (interleukin 18), CXCL10 (C-X-C motif chemokine ligand 10), CCL17 (C-C motif chemokine ligand 17), CX3CL1 (C-X3-C motif chemokine ligand 1), CCL2 (C-C motif chemokine ligand 2), IL1R1 (interleukin 1 receptor type 1), AGER (advanced glycosylation end-product specific receptor), BDNF (brain derived neurotrophic factor)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361] {aka A-152E5.3, ABCD-2, SCYA17, TARC}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, VSNL1 (visinin like 1) [NCBI Gene 7447] {aka HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1}, AQP1 (aquaporin 1 (Colton blood group)) [NCBI Gene 358] {aka AQP-CHIP, CHIP28, CO}, RBFOX3 (RNA binding fox-1 homolog 3) [NCBI Gene 146713] {aka FOX-3, FOX3, HRNBP3, NEUN}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209] {aka AD17, PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, IL37 (interleukin 37) [NCBI Gene 27178] {aka FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H, IL-1H4}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, CCR2 (C-C motif chemokine receptor 2) [NCBI Gene 729230] {aka CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2}, CLIC6 (CLIC family member 6) [NCBI Gene 54102] {aka CLIC1L}, IL1RN (interleukin 1 receptor antagonist) [NCBI Gene 3557] {aka CRMO2, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, TREM1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 54210] {aka CD354, TREM-1}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, RHOV (ras homolog family member V) [NCBI Gene 171177] {aka ARHV, CHP, WRCH2}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}
- **Diseases:** neuronal damage (MESH:D009410), infectious disease (MESH:D003141), neuropathology (MESH:D009422), coma (MESH:D003128), neurological disability (MESH:D009069), viral (MESH:D014777), astrocytosis (MESH:D005911), -term infection (MESH:D000088562), cytotoxic (MESH:D064420), Infection (MESH:D007239), Encephalitis (MESH:D004660), CPE (MESH:D065606), fever (MESH:D005334), neurological deficits (MESH:D009461), neuroinvasive disease (MESH:D004194), inflammation (MESH:D007249), headache (MESH:D006261), CNS (MESH:D002493), neuroinflammation (MESH:D000090862), WNV (MESH:D014901), neurotoxic (MESH:D020258)
- **Chemicals:** CO2 (MESH:D002245), citrate (MESH:D019343), formaldehyde (MESH:D005557), PBS (MESH:D007854), penicillin (MESH:D010406), glycerol (MESH:D005990), haematoxylin (MESH:D006416), 4',6-diamidin-2-phenylindol (-), fuchsine (MESH:C025485), E. (MESH:D004540), ethanol (MESH:D000431), paraffin (MESH:D010232), streptomycin (MESH:D013307), agar (MESH:D000362), PEG (MESH:D011092), xylene (MESH:D014992)
- **Species:** Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], West Nile virus (no rank) [taxon 11082], Macaca mulatta (rhesus macaque, species) [taxon 9544], Homo sapiens (human, species) [taxon 9606], Chlorocebus sabaeus (green monkey, species) [taxon 60711], Japanese encephalitis virus (no rank) [taxon 11072], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HMGU1 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_YT30), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), Vero — Chlorocebus sabaeus (Green monkey), Spontaneously immortalized cell line (CVCL_0059), Cer — Mus musculus (Mouse), Embryonic stem cell (CVCL_RZ01)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976376/full.md

---
Source: https://tomesphere.com/paper/PMC12976376